ESNº 10Deals & Finance

Biospringer by Lesaffre buys ModuMax taste tech from DSM-Firmenich

Biospringer by Lesaffre has acquired ModuMax, DSM-Firmenich's taste modulation portfolio, to cut bitterness and lift mouthfeel in reformulated drinks and dairy alternatives.

· 2 min at the table

Biospringer by Lesaffre acquires ModuMax taste modulation tech from DSM-Firmenich
Biospringer by Lesaffre acquires ModuMax taste modulation tech from DSM-FirmenichAI-generated

Menu du jour

  1. First course

    Biospringer by Lesaffre announced its acquisition of ModuMax from DSM-Firmenich on 29 October 2026.

  2. Second course

    ModuMax reduces bitterness, masks off-notes, strengthens mouthfeel, neutralises astringency and boosts creaminess.

  3. Third course

    Target applications include high-protein beverages, plant-based milk alternatives, reduced-sugar drinks and low-fat dairy alternatives.

  4. Fourth course

    ModuMax will be integrated into Biospringer's Go To Market organisation and global R&D and application network.

  5. Fifth course

    Taste is cited as the biggest barrier to consumer acceptance in better-for-you products.

Biospringer by Lesaffre has bought ModuMax, DSM-Firmenich's portfolio of taste modulation solutions, in a deal announced on 29 October 2026. The acquisition hands the fermentation and yeast ingredients specialist a multi-mechanism taste modulator that it will fold into its Go To Market organisation and its global R&D and application network.

The logic is straightforward. Food and beverage manufacturers keep reformulating products — cutting sugar, trimming fat, adding protein, swapping dairy for plants — and each change damages taste. ModuMax tackles that problem on several fronts at once. It reduces bitterness, masks off-notes, strengthens mouthfeel, neutralises astringency and boosts creaminess, all while improving overall flavour delivery.

Where does the technology land?

Biospringer names the target applications directly: high-protein beverages, plant-based milk alternatives, reduced-sugar drinks and low-fat dairy alternatives. These are the categories where reformulation pressure is highest and where taste failures are hardest to hide.

The company plans to combine ModuMax with its existing yeast extract range, which delivers depth, umami and kokumi. Together, the two platforms form what Biospringer calls integrated taste design platforms — toolkits that build richness and roundness into products that health-driven reformulation would otherwise strip out.

Carmen Arruda, global general director at Biospringer by Lesaffre, framed the deal as a portfolio play. "ModuMax is a powerful complement to our current portfolio," she said.

"By combining the depth, umami and kokumi of yeast extract with ModuMax's advanced modulation capabilities, we can help customers push the boundaries of nutritional reformulation without compromising taste," Arruda added.

Why does taste matter commercially?

Esther de Graaf-Groenendijk, food business line director at Biospringer, put the commercial case bluntly. Taste remains "the biggest barrier to consumer acceptance in better-for-you products," she said.

"With ModuMax, Biospringer now offers complete toolkits in the industry to help brands deliver healthier products that taste exceptional," de Graaf-Groenendijk added.

That barrier has a cost. Reformulated products that fail on taste don't get repeat purchases, and manufacturers know it. Ingredient suppliers that can guarantee taste performance in reduced-sugar, high-protein and plant-based formats hold real leverage with product development teams across Europe's food and beverage sector.

For DSM-Firmenich, the divestment trims a taste-modulation line from a portfolio built heavily around flavours and nutrition. For Lesaffre, the parent group, it deepens Biospringer's position in an ingredients niche — fermentation-derived taste solutions — where scale and application support decide who wins the reformulation briefs.

In plain terms: Biospringer now pairs yeast extracts with a proven masking and mouthfeel technology, and its sales teams can pitch both at once.

What happens next?

Biospringer will integrate ModuMax into its commercial and R&D operations globally, and the combined toolkits will be pitched to manufacturers working on nutritional reformulation across beverages, dairy alternatives and plant-based formats. Expect the first customer applications built on the combined platform to surface as the integration proceeds through 2026 and into 2027.

via FoodBev (Source)

Share this article:

More from Olivia Hart

Olivia Hart

Show full bio

Correspondent covering money, funding and market shifts around European hospitality industry at Eurotables Report.

136 articles

Other tables tonight

« Previous tableNext table »